SBLA - Clinical Results

Description

In a controlled clinical study, 100% of participants said their skin felt and looked hydrated and healthier.

FREE! Lip Plumper W/Purchase Limited Time Offer ONLY For, 60% OFF

argenx Reports Results of Vyvgart (efgartigimod alfa-fcab) in P-III (ADAPT-SC) Study for the Treatment of Generalized Myasthenia Gravis

Sanofi's ALTUVIIIO gets nod for hemophilia A care

Christie Brinkley's Secret to Youthful Neck & Chest – Great Beauty

BMS's Opdivo for Lung Cancer: US & EU Filings Accepted

FDA Grants Dupixent® sBLA Priority Review for Treatment of COPD with Type 2 Inflammation American Pharmaceutical Review - The Review of American Pharmaceutical Business & Technology

SBLA Physical Health Indicators - Overview

FDA Accepts for Priority Review the sBLA for Epcoritamab for Difficult-to-Treat Relapsed or Refractory Follicular Lymphoma

Eisai's SBLA Accepted For Traditional Approval Of LEQEMBI For Alzheimer's

USFDA accepts Eisai's sBLA and grants priority review for approval of LEQEMBITM Alzheimer's treatment - Express Pharma

Theratechnologies receives refusal to file letter for Trogarzo® intramuscular method of administration sBLA from FDA